Mimicking Human Pathophysiology in Organ-on-Chip Devices

65Citations
Citations of this article
140Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Convergence of life sciences, engineering, and basic sciences has opened new horizons for biologically inspired innovations, and a considerable number of organ-on-a-chip platforms have been developed for mimicking physiological systems of biological organs such as the brain, heart, lung, kidney, liver, and gut. Various biophysicochemical factors can also be introduced into such organ-on-a-chip platforms to study metabolic and systemic effects spanning from drug toxicity to different pathologic manifestations. There is also a pressing need to develop better disease models for common pathologies using variations of these platforms. This can be achieved by recapitulating the unique microenvironment of a disease to investigate the cause and development of abnormal conditions as well as the structural and functional changes resulting from such a pathology. In this review, the organ-on-a-chip platforms that have been developed to model different pathologies of neurodegenerative, cardiovascular, respiratory, hepatic, and digestive systems, along with cancer are summarized. Although the field is still in its infancy, it is anticipated that developing disease model-on-a-chip platforms will likely be a valuable addition to the field of disease modeling, pathology studies, and improved drug discovery.

Cite

CITATION STYLE

APA

Yesil-Celiktas, O., Hassan, S., Miri, A. K., Maharjan, S., Al-kharboosh, R., Quiñones-Hinojosa, A., & Zhang, Y. S. (2018, October 1). Mimicking Human Pathophysiology in Organ-on-Chip Devices. Advanced Biosystems. Wiley-VCH Verlag. https://doi.org/10.1002/adbi.201800109

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free